China has a broad future of the pharmaceutical products’ market. It can also provide the core resources and market for foreign enterprises in the entire pharmaceutical industry value chain: quality R & D team, adequate reserves of clinical doctors, as well as low-cost production capacity.

Although there is huge market potential, the medical industry is a highly competitive market, with huge risks. Companies need the right strategy and market insights in order to maintain its leading position in this field a long time. Clear understanding of the market and consumer segmentation is an important prerequisite for the successful occupation of key areas and to achieve profitability. Other challenges include: the innovation of the drug development process; bioinformatics and computing the results of biomedical; the impact of the biopharmaceutical; changes in the composition of the population and therapeutic areas; patent protection of the environment; potentially significant impact of drug patents expire and generic drugs to compete; health care plan adjustments; quality improvement of health care providers and management role; the promotion of commercial health insurance; retail change in the mode; the impact of IT and communication technology.

EBMRS in the Chinese pharmaceutical and healthcare industries throughout the value chain, leading companies to have extensive cooperation; our consultants have the deep expertise and long experience in the field of medicine. Our medical practice is including health care market research, pharmaceutical product, biotechnology, e-commerce, business strategy, market entry and growth strategy, market assessments, manufacturing and supply chain research, marketing strategy and consumer behavior.

For the business of our pharmaceutical and health care industry further information, please contact us.